Differences in the stability of prostacyclin in human, rabbit and rat plasma
- 28 February 1983
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 10 (2) , 109-114
- https://doi.org/10.1016/s0262-1746(83)80001-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- 6-Keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agentProstaglandins, 1980
- Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteriesProstaglandins, 1980
- Human platelet rich plasma and human serum protects from inactivation the antiaggregatory capacity of prostacyclin-like material (PGI2) produced by the rat stomach fundusProstaglandins, 1980
- Hypotensive and renovascular actions of 6-keto-prostaglandin E1, a metabolite of prostacyclinEuropean Journal of Pharmacology, 1979
- RECIRCULATION OF PROSTACYCLIN (PGI2) IN THE DOGBritish Journal of Pharmacology, 1978
- Chemical stability of prostacyclin (PGI2) in aqueous solutionsProstaglandins, 1978
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976